Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 9323804, 6 pages
http://dx.doi.org/10.1155/2016/9323804
Review Article

Sublingual Immunotherapy: A Useful Tool for the Allergist in Private Practice

Private Practice, 470 North Avenue, Elizabeth, NJ 07208, USA

Received 16 February 2016; Accepted 9 May 2016

Academic Editor: Ralph Mösges

Copyright © 2016 Diego Saporta. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. H. Curtis, The Immunizing Cure of Hay Fever, vol. 77, Med News, New York, NY, USA, 1900.
  2. G. W. Canonica and G. Passalacqua, “Noninjection routes for immunotherapy,” Journal of Allergy and Clinical Immunology, vol. 111, no. 3, pp. 437–448, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Bousquet, P. Van Cauwenberge, N. Khaltaev et al., “Allergic rhinitis and its impact on asthma,” Journal of Allergy and Clinical Immunology, vol. 108, no. 5, pp. 242–245, 2001. View at Google Scholar
  4. J. Bousquet, “The new ARIA guidelines: putting science into practice,” Clinical and Experimental Allergy Reviews, vol. 2, no. 1, pp. 38–43, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. D. R. Wilson, M. T. Lima, and S. R. Durham, “Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis,” Allergy, vol. 60, no. 1, pp. 4–12, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. L. S. Cox, D. L. Linnemann, H. Nolte, D. Weldon, I. Finegold, and H. S. Nelson, “Sublingual immunotherapy: a comprehensive review,” Journal of Allergy and Clinical Immunology, vol. 117, no. 5, pp. 1021–1035, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Penagos, E. Compalati, F. Tarantini et al., “Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials,” Annals of Allergy, Asthma and Immunology, vol. 97, no. 2, pp. 141–148, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Penagos, G. Passalacqua, E. Compalati et al., “Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age,” Chest, vol. 133, no. 3, pp. 599–609, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Makatsori and M. A. Calderon, “Anaphylaxis: still a ghost behind immunotherapy,” Current Opinion in Allergy and Clinical Immunology, vol. 14, no. 4, pp. 316–322, 2014. View at Google Scholar · View at Scopus
  10. T. G. Epstein, G. M. Liss, K. Murphy-Berendts, and D. I. Bernstein, “AAAAI/ACAAI surveillance study of subcutaneous immunotherapy, years 2008–2012: an update on fatal and nonfatal systemic allergic reactions,” Journal of Allergy and Clinical Immunology: In Practice, vol. 2, no. 2, pp. 161.e3–167.e3, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. P. R. Cook, J. L. Bryant II, W. E. Davis, T. T. Benke, and A. S. Rapoport, “Systemic reactions to immunotherapy: the American Academy of Otolaryngic Allergy Morbidity and Mortality Survey,” Otolaryngology—Head and Neck Surgery, vol. 110, no. 6, pp. 487–493, 1994. View at Google Scholar · View at Scopus
  12. W. E. Davis, P. R. Cook, J. P. McKinsey, and J. W. Templer, “Anaphylaxis in immunotherapy,” Otolaryngology—Head and Neck Surgery, vol. 107, no. 1, pp. 78–83, 1992. View at Publisher · View at Google Scholar · View at Scopus
  13. R. F. Lockey, L. M. Benedict, P. C. Turkeltaub, and S. C. Bukantz, “Fatalities from immunotherapy (IT) and skin testing (ST),” The Journal of Allergy and Clinical Immunology, vol. 79, no. 4, pp. 660–677, 1987. View at Publisher · View at Google Scholar · View at Scopus
  14. D. I. Bernstein, M. Wanner, L. Borish et al., “Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990–2001,” Journal of Allergy and Clinical Immunology, vol. 113, no. 6, pp. 1129–1136, 2004. View at Google Scholar
  15. T. G. Epstein, G. M. Liss, K. Murphy-Berendts, and D. I. Bernstein, “AAAAI/ACAAI surveillance study of subcutaneous immunotherapy, years 2008–2012: an update on fatal and nonfatal systemic allergic reactions,” Journal of Allergy and Clinical Immunology: In Practice, vol. 2, no. 2, pp. 161–167.e3, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Ciprandi and G. L. Marseglia, “Safety of sublingual immunotherapy,” Journal of Biological Regulators and Homeostatic Agents, vol. 25, no. 1, pp. 1–6, 2011. View at Google Scholar · View at Scopus
  17. G. B. Pajno, D. G. Peroni, D. Vita, A. Pietrobelli, S. Parmiani, and A. L. Boner, “Safety of sublingual immunotherapy in children with asthma,” Pediatric Drugs, vol. 5, no. 11, pp. 777–781, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Agostinis, C. Foglia, M. Landi et al., “The safety of sublingual immunotherapy with one or multiple pollen allergens in children,” Allergy, vol. 63, no. 12, pp. 1637–1639, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Radulovic, D. Wilson, M. Calderon, and S. Durham, “Systematic reviews of sublingual immunotherapy (SLIT),” Allergy, vol. 66, no. 6, pp. 740–752, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. B. D. Leatherman, A. Khalid, S. Lee et al., “Dosing of sublingual immunotherapy for allergic rhinitis: evidence-based review with recommendations,” International Forum of Allergy and Rhinology, vol. 5, no. 9, pp. 773–783, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. M. A. Calderõn, F. E. R. Simons, H.-J. Malling, R. F. Lockey, P. Moingeon, and P. Demoly, “Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile,” Allergy, vol. 67, no. 3, pp. 302–311, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Marogna, I. Spadolini, A. Massolo et al., “Effects of sublingual immunotherapy for multiple or single allergens in polysensitized patients,” Annals of Allergy, Asthma and Immunology, vol. 98, no. 3, pp. 274–280, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. A. O. Eifan, S. Keles, N. N. Bahceciler, and I. B. Barlan, “Anaphylaxis to multiple pollen allergen sublingual immunotherapy,” Allergy, vol. 62, no. 5, pp. 567–568, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. R. L. Mabry, Skin End Point Titration, AAOA Monograph Series, Thieme Medical Publishers, New York, NY, USA, 1994.
  25. J. A. Fornadley, “Skin testing in the diagnosis of inhalant allergy,” in Allergy and Immunology, an Otolaryngic Approach, J. H. Krouse, S. J. Chadwick, B. R. Gordon, and M. J. Derebery, Eds., pp. 114–123, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2002. View at Google Scholar
  26. S. Elenburg and M. S. Blaiss, “Current status of sublingual immunotherapy in the United States,” World Allergy Organization Journal, vol. 7, no. 1, article 24, 2014. View at Publisher · View at Google Scholar
  27. D. Saporta and A. B. McDaniel, “Efficacy comparison of multiple-antigen subcutaneous injection immunotherapy and multiple-antigen sublingual immunotherapy,” Ear, Nose and Throat Journal, vol. 86, no. 8, pp. 493–497, 2007. View at Google Scholar · View at Scopus
  28. D. Saporta, “Efficacy of sublingual immunotherapy versus subcutaneous injection immunotherapy in allergic patients,” Journal of Environmental and Public Health, vol. 2012, Article ID 492405, 6 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Chang, D. H. Han, J.-H. Mo et al., “Early compliance and efficacy of sublingual immunotherapy in patients with allergic rhinitis for house dust mites,” Clinical and Experimental Otorhinolaryngology, vol. 2, no. 3, pp. 136–140, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Fiocchi, G. Pajno, S. La Grutta et al., “Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years,” Annals of Allergy, Asthma and Immunology, vol. 95, no. 3, pp. 254–258, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Passalacqua, C. E. Baena-Cagnani, J. Bousquet et al., “Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language,” Journal of Allergy and Clinical Immunology, vol. 132, no. 1, pp. 93–98, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. G. B. Gidaro, F. Marcucci, L. Sensi, C. Incorvaia, F. Frati, and G. Ciprandi, “The safety of sublingual-swallow immunotherapy: an analysis of published studies,” Clinical & Experimental Allergy, vol. 35, no. 5, pp. 565–571, 2005. View at Publisher · View at Google Scholar
  33. A. Didier, M. Worm, F. Horak et al., “Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis,” Journal of Allergy and Clinical Immunology, vol. 128, no. 3, pp. 559–566, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Passalacqua, L. Guerra, E. Compalati, and G. W. Canonica, “The safety of allergen specific sublingual immunotherapy,” Current Drug Safety, vol. 2, no. 2, pp. 117–123, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Passalacqua, L. Guerra, F. Fumagalli, and G. W. Canonica, “Safety profile of sublingual immunotherapy,” Treatments in Respiratory Medicine, vol. 5, no. 4, pp. 225–234, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Passalacqua and G. W. Canonica, “Sublingual immunotherapy for allergic respiratory diseases: efficacy and safety,” Immunology and Allergy Clinics of North America, vol. 31, no. 2, pp. 265–277, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. D. Saporta, Reactions to Sublingual Immunotherapy: An Analysis of a Group of Patients Who Developed Adverse Events over a Period of 5 Years. Does Glycerin play a role? Townsend Letter, August/September 2014.
  38. M. D. Ibañez, F. Kaiser, R. Knecht et al., “Safety of specific sublingual immunotherapy with SQ standardized grass allergen tablets in children,” Pediatric Allergy and Immunology, vol. 18, no. 6, pp. 516–522, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. H. S. Nelson, H. Nolte, P. Creticos, J. Maloney, J. Wu, and D. I. Bernstein, “Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults,” Journal of Allergy and Clinical Immunology, vol. 127, no. 1, pp. 72.e2–80.e2, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Blaiss, J. Maloney, H. Nolte et al., “Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents,” Journal of Allergy and Clinical Immunology, vol. 127, no. 1, pp. 64–71, 2011. View at Publisher · View at Google Scholar
  41. L. S. Cox, T. B. Casale, A. S. Nayak et al., “Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE,” Journal of Allergy and Clinical Immunology, vol. 130, no. 6, pp. 1327–1334, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. P. S. Creticos, R. E. Esch, P. Couroux et al., “Randomized, double-blind, placebo-controlled trial of standardized ragweed sublingual-liquid immunotherapy for allergic rhinoconjunctivitis,” Journal of Allergy and Clinical Immunology, vol. 133, no. 3, pp. 751–758, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Lombardi, F. Gani, M. Landi et al., “Quantitative assessment of the adherence to sublingual immunotherapy,” Journal of Allergy and Clinical Immunology, vol. 113, no. 6, pp. 1219–1220, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. G. B. Pajno, L. Morabito, G. Barberio, and S. Parmiani, “Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study,” Allergy, vol. 55, no. 9, pp. 842–849, 2000. View at Publisher · View at Google Scholar · View at Scopus
  45. Joint Task Force on Practice Parameters, “Allergy immunotherapy: a practice parameter. American Academy of Allergy Asthma and Immunology,” Annals of Allergy, Asthma & Immunology, vol. 90, no. 1, supplement 1, pp. 1–40, 2003. View at Google Scholar
  46. O. Linna, J. Kokkonen, and M. Lukin, “A 10-year prognosis for childhood allergic rhinitis,” Acta Paediatrica, vol. 81, no. 2, pp. 100–102, 1992. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Bousquet, P. Demoly, and F.-B. Michel, “Specific immunotherapy in rhinitis and asthma,” Annals of Allergy, Asthma and Immunology, vol. 87, no. 1, pp. 38–42, 2001. View at Publisher · View at Google Scholar · View at Scopus
  48. C. Möller, S. Dreborg, H. A. Ferdousi et al., “Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-Study),” Journal of Allergy and Clinical Immunology, vol. 109, no. 2, pp. 251–256, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Des Roches, L. Paradis, J.-L. Menardo, S. Bouges, J.-P. Daurés, and J. Bousquet, “Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children,” Journal of Allergy and Clinical Immunology, vol. 99, no. 4, pp. 450–453, 1997. View at Publisher · View at Google Scholar · View at Scopus
  50. F. Agostinis, L. Tellarini, G. W. Canonica, P. Falagiani, and G. Passalacqua, “Safety of sublingual immunotherapy with a monomeric allergoid in very young children,” Allergy, vol. 60, no. 1, p. 133, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. D. Saporta, “SLIT and asthma,” Townsend Letter, vol. 327, pp. 44–48, 2010. View at Google Scholar
  52. D. Saporta, “Changes in peak flow value during immunotherapy administration,” Journal of Environmental and Public Health, vol. 2012, Article ID 212867, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. J. H. Krouse, R. W. Brown, S. M. Fineman et al., “Asthma and the unified airway,” Otolaryngology—Head and Neck Surgery, vol. 136, no. 5, pp. S75–S106, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. R. F. Lockey, L. M. Benedict, P. C. Turkeltaub, and S. C. Bukantz, “Fatalities from immunotherapy (IT) and skin testing (ST),” The Journal of Allergy and Clinical Immunology, vol. 79, no. 4, pp. 660–677, 1987. View at Publisher · View at Google Scholar · View at Scopus
  55. A. T. Borchers, C. L. Keen, and M. E. Gershwin, “Fatalities following allergen immunotherapy,” Clinical Reviews in Allergy and Immunology, vol. 27, no. 2, pp. 147–158, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. W. A. Shaikh, “A retrospective study on the safety of immunotherapy in pregnancy,” Clinical and Experimental Allergy, vol. 23, no. 10, pp. 857–860, 1993. View at Publisher · View at Google Scholar · View at Scopus
  57. W. A. Shaikh and S. W. Shaikh, “A prospective study on the safety of sublingual immunotherapy in pregnancy,” Allergy, vol. 67, no. 6, pp. 741–743, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Bagnasco, G. Mariani, G. Passalacqua et al., “Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectable routes in healthy human beings,” The Journal of Allergy and Clinical Immunology, vol. 100, no. 1, pp. 122–129, 1997. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Bagnasco, G. Passalacqua, G. Villa et al., “Pharmacokinetics of an allergen and a monomeric allergoid for oromucosal immunotherapy in allergic volunteers,” Clinical and Experimental Allergy, vol. 31, no. 1, pp. 54–60, 2001. View at Publisher · View at Google Scholar · View at Scopus
  60. L. Cox and L. Jacobsen, “Comparison of allergen immunotherapy practice patterns in the United States and Europe,” Annals of Allergy, Asthma and Immunology, vol. 103, no. 6, pp. 451–460, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. B. Lundbäck, “Epidemiology of rhinitis and asthma,” Clinical and Experimental Allergy, Supplement, vol. 28, no. 2, pp. 3–10, 1998. View at Google Scholar · View at Scopus
  62. R. Pawankar, G. W. Canonica, S. T. Holgate, and R. F. Lockey, Eds., WAO White Book on Allergy, World Allergy Organization (WAO), Milwaukee, Wis, USA, 2012.
  63. D. Saporta, “Changes in skin allergy testing reactivity observed after a hurricane. Is the environment responsible?” SOJ Immunology, vol. 3, no. 3, pp. 1–6, 2015. View at Publisher · View at Google Scholar
  64. Topic: Recent FDA Approvals, 2016, http://www.aaoaf.org/PR.aspx?PAGE_ID=233.